IL118546A - Corn oil transesterification products - Google Patents

Corn oil transesterification products

Info

Publication number
IL118546A
IL118546A IL11854692A IL11854692A IL118546A IL 118546 A IL118546 A IL 118546A IL 11854692 A IL11854692 A IL 11854692A IL 11854692 A IL11854692 A IL 11854692A IL 118546 A IL118546 A IL 118546A
Authority
IL
Israel
Prior art keywords
weight
product
glycerides
tri
mono
Prior art date
Application number
IL11854692A
Other languages
English (en)
Hebrew (he)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10697415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL118546(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IL118546A publication Critical patent/IL118546A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
    • C11C3/04—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils
    • C11C3/06—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils with glycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nanotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fats And Perfumes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Confectionery (AREA)
IL11854692A 1991-06-27 1992-06-25 Corn oil transesterification products IL118546A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919113872A GB9113872D0 (en) 1991-06-27 1991-06-27 Improvements in or relating to organic compounds
IL102310A IL102310A (en) 1991-06-27 1992-06-25 Pharmaceutical compositions comprising cyclosporins

Publications (1)

Publication Number Publication Date
IL118546A true IL118546A (en) 1998-09-24

Family

ID=10697415

Family Applications (3)

Application Number Title Priority Date Filing Date
IL11854692A IL118546A (en) 1991-06-27 1992-06-25 Corn oil transesterification products
IL102310A IL102310A (en) 1991-06-27 1992-06-25 Pharmaceutical compositions comprising cyclosporins
IL11854696A IL118546A0 (en) 1991-06-27 1996-06-03 Transesterified corn oil products

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL102310A IL102310A (en) 1991-06-27 1992-06-25 Pharmaceutical compositions comprising cyclosporins
IL11854696A IL118546A0 (en) 1991-06-27 1996-06-03 Transesterified corn oil products

Country Status (38)

Country Link
EP (2) EP0539319B1 (ja)
JP (2) JP2653958B2 (ja)
KR (3) KR0131064B1 (ja)
CN (1) CN1077798C (ja)
AT (1) AT403436B (ja)
AU (1) AU659460B2 (ja)
CA (2) CA2175842C (ja)
CH (2) CH684163A5 (ja)
CY (1) CY1906A (ja)
CZ (1) CZ281790B6 (ja)
DE (3) DE4244930C2 (ja)
DK (2) DK0953630T3 (ja)
EE (1) EE03108B1 (ja)
ES (2) ES2142818T3 (ja)
FI (2) FI109454B (ja)
FR (2) FR2678169B1 (ja)
GB (2) GB9113872D0 (ja)
GR (1) GR3032366T3 (ja)
HK (2) HK57196A (ja)
HU (1) HU216792B (ja)
IE (1) IE73662B1 (ja)
IL (3) IL118546A (ja)
IT (1) IT1254401B (ja)
LU (1) LU88138A1 (ja)
MX (1) MX9203236A (ja)
MY (1) MY109512A (ja)
NO (2) NO303964B1 (ja)
NZ (1) NZ243309A (ja)
PH (1) PH30337A (ja)
PT (2) PT539319E (ja)
RO (2) RO111021B1 (ja)
RU (1) RU2143919C1 (ja)
SA (1) SA92130213B1 (ja)
SK (1) SK278759B6 (ja)
TW (1) TW267943B (ja)
UA (1) UA35559C2 (ja)
UY (1) UY23864A1 (ja)
ZA (1) ZA924719B (ja)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
PT589843E (pt) * 1992-09-25 2002-04-29 Novartis Ag Composicoes farmaceuticas contendo ciclosporinas
NZ247516A (en) * 1993-04-28 1995-02-24 Bernard Charles Sherman Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant
CH686761A5 (de) * 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
AT408520B (de) * 1993-05-27 2001-12-27 Novartis Erfind Verwalt Gmbh Galenische formulierungen
GB2278780B (en) * 1993-05-27 1998-10-14 Sandoz Ltd Macrolide formulations
EP0649651B1 (en) * 1993-09-28 2000-12-13 R.P. Scherer GmbH Soft gelatin capsule manufacture
DE4340781C3 (de) * 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
EP0694308A4 (en) * 1994-02-17 1997-09-10 Shiseido Co Ltd CYCLOSPORIN EMULSION COMPOSITION
US5891846A (en) * 1994-02-17 1999-04-06 Shiseido Company, Ltd. Cyclosporin-containing emulsion composition
NZ270145A (en) * 1994-03-01 1996-08-27 Lilly Co Eli Non-aqueous pharmaceutical formulation for oral administration comprising water-insoluble active agent, fatty acid solubilising agent, an oil and a surface active agent
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
EP0679712B1 (en) * 1994-03-31 1999-06-23 Loders Croklaan B.V. Low safa oils
IL115742A (en) 1994-10-26 2000-06-01 Novartis Ag Pharmaceutical compositions comprising a difficultly soluble active agent a hydrophilic phase a lipophilic phase and a surfactant
GB2308545B (en) * 1994-10-26 1999-06-02 Novartis Ag Pharmaceutical microemulsion preconcentrates
SK164796A3 (en) 1994-11-03 1997-06-04 Dresden Arzneimittel Novel cyclosporine preparation forms for oral administration of and process for producing them
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
WO1996036330A2 (en) * 1995-05-17 1996-11-21 Cedars-Sinai Medical Center Compositions containing fatty acids for improving digestion and absorption in the small intestine
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
CA2220451A1 (en) * 1995-05-17 1996-11-21 Cedars-Sinai Medical Center Methods and compositions for improving digestion and absorption in the small intestine
US6008228A (en) * 1995-06-06 1999-12-28 Hoffman-La Roche Inc. Pharmaceutical compositions containing proteinase inhibitors
US6696413B2 (en) * 1995-06-16 2004-02-24 Hexal Ag Pharmaceutical preparation with cyclosporin A
SE504582C2 (sv) * 1995-07-06 1997-03-10 Gs Dev Ab Cyklosporinkomposition baserad på en L2-fas
DE19549852B4 (de) * 1995-11-29 2009-06-04 Novartis Ag Cyclosporin enthaltende Präparate
US5858401A (en) 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
CN1104258C (zh) * 1996-05-29 2003-04-02 周德和 用于环孢霉素a的赋形剂
US5958876A (en) * 1996-06-19 1999-09-28 Novartis Ag Cyclosporin-containing pharmaceutical compositions
MY117765A (en) * 1996-06-19 2004-08-30 Novartis Ag Cyclosporin-containing soft capsule preparations.
KR980008239A (ko) * 1996-07-26 1998-04-30 김충환 사이클로스포린-함유 약학적 조성물
FR2752732B1 (fr) * 1996-08-28 1998-11-20 Pf Medicament Forme galenique a liberation prolongee de milnacipran
ZA9711732B (en) 1996-12-31 1998-12-28 Quadrant Holdings Cambridge Methods and compositions for improvement bioavailability of bioactive agents for mucosal delivery
US6306434B1 (en) * 1997-02-12 2001-10-23 Chong Kun Dang Corp. Pharmaceutical composition comprising cyclosporin solid-state microemulsion
IL131609A0 (en) * 1997-03-12 2001-01-28 Abbott Lab Hydrophilic binary systems for the administration of cyclosporine
AR012627A1 (es) 1997-04-29 2000-11-08 Sherman Bernard Charles Pre-concentrado de emulsion que comprende una ciclosporina y monoglicerido acetilado
NZ314702A (en) * 1997-04-29 1998-07-28 Bernard Charles Sherman Pharmaceutical composition comprising a cyclosporin in a solvent system of acetylated monoglycerides and a surfactant and optionally a hydrophilic solvent
GB2326337A (en) 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
PT999826E (pt) * 1997-07-29 2004-09-30 Upjohn Co Formulacao auto-emulsionante para compostos lipofilos
ES2184310T3 (es) 1997-07-29 2003-04-01 Upjohn Co Formulacion autoemulsionante para compuestos lipofilos acidos.
ES2174462T3 (es) * 1997-07-29 2002-11-01 Upjohn Co Formulacion autoestimulante para compuestos lipofilos.
US6657104B1 (en) 1997-10-16 2003-12-02 Texas Systems, University Of The Board Of The Regents Transgenic mouse model for cardiac hypertrophy and methods of use thereof
US6284268B1 (en) 1997-12-10 2001-09-04 Cyclosporine Therapeutics Limited Pharmaceutical compositions containing an omega-3 fatty acid oil
ID25908A (id) * 1998-03-06 2000-11-09 Novartis Ag Prakonsentrat-prakonsentrat emulsi yang mengandung siklosporin atau makrolida
ES2215277T3 (es) * 1998-08-18 2004-10-01 Panacea Biotec Limited Composicion de ciclosporina que comprende un vehiculo hidrofilo.
GB9903547D0 (en) 1999-02-16 1999-04-07 Novartis Ag Organic compounds
CN1167462C (zh) * 1999-03-09 2004-09-22 杭州华东医药集团生物工程研究所有限公司 一种含环孢素的药物组合物
US6956048B2 (en) 1999-03-31 2005-10-18 Pharmacia & Upjohn Company Pharmaceutical emulsions for retroviral protease inhibitors
WO2001032143A1 (en) * 1999-11-02 2001-05-10 Cipla Ltd. A pharmaceutical composition for the administration of water-insoluble pharmaceutically active substances and a process for preparation thereof
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
GB0008785D0 (en) 2000-04-10 2000-05-31 Novartis Ag Organic compounds
US7008661B2 (en) 2000-08-08 2006-03-07 Kao Corporation Oil/fat composition
US7115565B2 (en) 2001-01-18 2006-10-03 Pharmacia & Upjohn Company Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
KR100982466B1 (ko) 2001-10-19 2010-09-16 이소테크니카 인코포레이티드 시클로스포린 유사체의 합성
KR100441167B1 (ko) * 2001-12-27 2004-07-21 씨제이 주식회사 마이크로에멀젼 예비 농축액 조성물
KR100525234B1 (ko) * 2003-02-19 2005-10-28 한국유나이티드제약 주식회사 사이클로스포린 함유 연질캅셀제 및 그 제조방법
GT200500310A (es) 2004-11-19 2006-06-19 Compuestos organicos
GB0504950D0 (en) 2005-03-10 2005-04-20 Novartis Ag Organic compositions
JP4889262B2 (ja) * 2005-08-19 2012-03-07 理研ビタミン株式会社 脂溶性薬剤組成物
MD3347G2 (ro) * 2006-12-26 2008-01-31 Институт Сельскохозяйственной Техники "Mecagro" Procedeu de obţinere a esterilor metilici din ulei de rapiţă
ITPD20070049A1 (it) * 2007-02-14 2008-08-15 Sila S R L Prodotto a base di acido linoleico coniugato e processo per la sua fabbricazione
JP2010523554A (ja) 2007-04-04 2010-07-15 シグモイド・ファーマ・リミテッド タクロリムスの医薬組成物
CN101199836B (zh) * 2007-11-07 2011-03-30 安徽省药物研究所 一种阶段释放型环孢素a固体微乳制剂及其微乳固化方法
GB2483815B (en) 2009-05-18 2013-12-25 Sigmoid Pharma Ltd Composition comprising oil drops
CN107582526A (zh) 2009-08-12 2018-01-16 希格默伊德药业有限公司 包含聚合物基质和油相的免疫调节组合物
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
JO3337B1 (ar) 2010-12-13 2019-03-13 Debiopharm Sa تركيبات صيدلية تشمل أليسبوريفير
FR2971941B1 (fr) 2011-02-24 2013-08-02 Physica Pharma Compositions pharmaceutiques administrables par voie cutanee et destinees au traitement local de la dermatite atopique canine
GB201304662D0 (en) 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
AU2015341695B2 (en) 2014-11-07 2021-07-08 Sublimity Therapeutics Limited Compositions comprising cyclosporin
WO2020050182A1 (ja) * 2018-09-06 2020-03-12 株式会社カマタ カプセル充填用液状組成物及びカプセル剤
FI3886813T3 (fi) * 2018-11-26 2023-05-04 Hepion Pharmaceuticals Inc Syklosporiinianalogien farmaseuttisia formulaatioita

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1274354A (fr) * 1956-03-10 1961-10-27 Agents tensio-actifs obtenus à partir de triglycérides et polyéthylène glycol
SE445174B (sv) * 1978-03-07 1986-06-09 Sandoz Ag Farmaceutisk komposition innehallande en cyklosporin och en berarsubstans
CH641356A5 (en) * 1979-02-27 1984-02-29 Sandoz Ag Pharmaceutical compositions containing cyclosporin
AU558155B2 (en) * 1982-02-01 1987-01-22 Sandoz Ltd. Treating multiple sclerosis with dihydro-cyclosporin d
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
JPS62201591A (ja) * 1986-02-28 1987-09-05 Shoichi Shimizu 油脂のグリセロリシス法
JP2632010B2 (ja) * 1988-01-29 1997-07-16 三共株式会社 シクロスポリン製剤
CH679119A5 (ja) * 1988-05-13 1991-12-31 Sandoz Ag
HU201567B (en) * 1988-07-21 1990-11-28 Gyogyszerkutato Intezet Process for production of intravenous medical compositions containing cyclosphorin
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
GB8823621D0 (en) * 1988-10-07 1988-11-16 Madhok R Compositions containing cyclosporins
JPH0738771B2 (ja) * 1989-01-17 1995-05-01 花王株式会社 液状食用油組成物
FR2642650B1 (fr) * 1989-02-09 1994-12-09 Sandoz Sa Nouvelles compositions pharmaceutiques a base de cyclosporines
AU6785490A (en) * 1989-12-18 1991-06-20 Kraft General Foods, Inc. Low-saturate edible oils and transesterification methods for production thereof
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
KR100231385B1 (en) 1999-11-15
CH685764A5 (de) 1995-09-29
CA2072509A1 (en) 1992-12-28
AT403436B (de) 1998-02-25
PT539319E (pt) 2000-05-31
FR2678169B1 (fr) 1994-08-26
NO325267B1 (no) 2008-03-17
JPH09118894A (ja) 1997-05-06
NO922506L (no) 1992-12-28
FR2685706A1 (fr) 1993-07-02
CH684163A5 (de) 1994-07-29
GB9213393D0 (en) 1992-08-05
DK0953630T3 (da) 2004-11-01
SK278759B6 (sk) 1998-02-04
KR0131064B1 (ko) 1998-04-17
NO922506D0 (no) 1992-06-25
EP0539319A2 (en) 1993-04-28
ES2142818T3 (es) 2000-05-01
MY109512A (en) 1997-02-28
UA35559C2 (uk) 2001-04-16
FI961513A (fi) 1996-04-03
FI961513A0 (fi) 1996-04-03
CY1906A (en) 1992-06-24
GR3032366T3 (en) 2000-04-27
FR2678169A1 (fr) 1992-12-31
EP0953630B1 (en) 2004-09-08
IL118546A0 (en) 1996-10-16
HK157696A (en) 1996-08-30
EP0953630A1 (en) 1999-11-03
CA2175842A1 (en) 1992-12-28
IE922082A1 (en) 1992-12-30
ITRM920476A0 (it) 1992-06-23
CN1079907A (zh) 1993-12-29
CA2175842C (en) 2002-05-07
DE4244930C2 (de) 1999-11-11
HUT62201A (en) 1993-04-28
DE4219526C2 (de) 1999-04-22
IT1254401B (it) 1995-09-14
FI109454B (fi) 2002-08-15
HU9201975D0 (en) 1992-09-28
CZ197792A3 (en) 1993-01-13
IE73662B1 (en) 1997-06-18
IL102310A0 (en) 1993-01-14
NO303964B1 (no) 1998-10-05
MX9203236A (es) 1992-12-01
SA92130213B1 (ar) 2004-07-24
JPH05186365A (ja) 1993-07-27
GB9113872D0 (en) 1991-08-14
RU2143919C1 (ru) 2000-01-10
PT953630E (pt) 2004-11-30
FI922958A (fi) 1992-12-28
ES2227921T3 (es) 2005-04-01
EP0539319B1 (en) 1999-12-08
JP3420897B2 (ja) 2003-06-30
NZ243309A (en) 1995-02-24
GB2257359B (en) 1996-01-10
CZ281790B6 (cs) 1997-01-15
FI922958A0 (fi) 1992-06-25
KR100231384B1 (en) 1999-11-15
PH30337A (en) 1997-04-02
RO111110B1 (ro) 1996-06-28
FI116199B (fi) 2005-10-14
ZA924719B (en) 1993-12-27
LU88138A1 (fr) 1994-03-01
TW267943B (ja) 1996-01-11
NO964382L (no) 1992-12-28
AU1852792A (en) 1993-03-11
IL102310A (en) 1997-03-18
CA2072509C (en) 1996-07-30
SK197792A3 (en) 1994-03-09
KR930000113A (ko) 1993-01-15
EP0539319A3 (en) 1993-06-09
RO111021B1 (ro) 1996-06-28
JP2653958B2 (ja) 1997-09-17
CN1077798C (zh) 2002-01-16
NO964382D0 (no) 1996-10-15
UY23864A1 (es) 1995-05-29
EE03108B1 (et) 1998-08-17
ITRM920476A1 (it) 1993-12-23
AU659460B2 (en) 1995-05-18
ATA129892A (de) 1997-07-15
HU216792B (hu) 1999-08-30
DK0539319T3 (da) 2000-05-22
HK57196A (en) 1996-04-12
DE4244986B4 (de) 2008-07-24
FR2685706B1 (ja) 1994-12-23
DE4219526A1 (de) 1993-03-18
GB2257359A (en) 1993-01-13

Similar Documents

Publication Publication Date Title
EP0953630B1 (en) Transesterification products of corn oil and glycerol and their use in pharmaceutical compositions
CA2366754C (en) Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants
US6420355B2 (en) Pharmaceutical compositions containing cyclosporins
US6652880B1 (en) Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants
CZ291214B6 (cs) Potravinářský prostředek s obsahem organického gelu
EP1079699B1 (en) Water-in-oil emulsified fat composition
IE84659B1 (en) Transesterified corn oil products
AU688920B2 (en) Transesterified corn oil products
JPH10330250A (ja) メナテトレノン油性製剤
Kartha High‐order compositeness in randomly distributed natural fats: Glyceride structure of an arecanut fat

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired